Defining the ligand specificity of the deleted in colorectal cancer (DCC) receptor

Area of Science:

• Neuroscience
• Molecular Biology
• Developmental Biology

Background:

• Axon growth and guidance in the developing nervous system depend on Netrin-mediated activation of Deleted in Colorectal Cancer (DCC) and other signaling cues.
• More severe commissural axon guidance defects in DCC mutant mice than Netrin-1 mutant mice suggest additional DCC-activating signals beyond Netrin-1.

Purpose of the Study:

• To identify novel extracellular DCC-binding partners involved in axon guidance.
• To characterize the interaction between Cerebellin 4 (CBLN4) and DCC.

Main Methods:

• Extracellular protein microarrays screening over 1,000 proteins to identify DCC-binding partners.
• Immunofluorescence and radio-ligand binding assays to confirm and quantify binding interactions.
• Analysis of CBLN4-null mice for axon guidance phenotypes.

Main Results:

• Cerebellin 4 (CBLN4) and Netrin-1 were identified as extracellular DCC-binding partners.
• Netrin-1 competes with CBLN4 for binding to DCC at an overlapping site (fibronectin domains 4-6) with higher affinity.
• CBLN4 also binds to Neogenin-1 (NEO1) with lower affinity; CBLN4-null mice showed transient wandering axon phenotypes in the brachial plexus.

Conclusions:

• Cerebellin 4 (CBLN4) is confirmed as a bona fide ligand for Deleted in Colorectal Cancer (DCC).
• CBLN4 plays a role in axon guidance, potentially complementing Netrin-1 signaling.
• These findings deepen the understanding of molecular mechanisms regulating neural circuit formation.